Richard Aplenc
Pediatric Oncology
University of Pennsylvania
Philadelphia
PA 19104
USA
Name/email consistency: high
- Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group. Aplenc, R., Alonzo, T.A., Gerbing, R.B., Smith, F.O., Meshinchi, S., Ross, J.A., Perentesis, J., Woods, W.G., Lange, B.J., Davies, S.M. Blood (2006)
- Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia. Aplenc, R., Thompson, J., Han, P., La, M., Zhao, H., Lange, B., Rebbeck, T. Cancer Res. (2005)
- Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia. Aplenc, R., Lange, B. Br. J. Haematol. (2004)
- Genetic polymorphisms of CYP1A1, CYP2D6, GSTM1, and GSTT1 and susceptibility to acute lymphoblastic leukemia in Indian children. Aplenc, R. Pediatr. Blood. Cancer (2004)
- Group sequential methods and sample size savings in biomarker-disease association studies. Aplenc, R., Zhao, H., Rebbeck, T.R., Propert, K.J. Genetics (2003)
- Pharmacogenetics of gemtuzumab-associated hepatic sinusoidal occlusion syndrome after hematopoietic stem cell transplant. Aplenc, R., Vachani, A., Han, P., Glatfelter, W., Sievers, E.L. Acta Haematol. (2003)